
Multi-million pound fund manager Neil Woodford has renewed his call for GSK to break up into separate business units, amid …

Roche has announced plans to restructure its manufacturing network for small molecules, in a move that will see it mothball …
Merck Group has rebranded to “reflect its transformation into a science and technology company”, and restructured its business to create …

Lundbeck is cutting a thousand jobs globally as part of a restructuring programme to significantly lower its cost and focus …

Novartis has confirmed that it will cease all of its pharmaceutical operations at its Horsham, West Sussex site this year. …

Pfizer is to restructure operations from January 2014 in a bid to make its business more responsive to patient and …
Johnson & Johnson has announced further restructuring that will see more than 8,000 jobs being cut.The conglomerate says that it …
Pfizer is to close six research sites in the US and two in the UK to create its new streamlined …
The new corporate entity formed by the Merck & Co/Schering-Plough merger has at last opened its doors for business.The Schering-Plough …
The completion of Pfizer’s deal to acquire Wyeth has been followed swiftly by news that a number of manufacturing and …
Pfizer expects to complete its $68 billion acquisition of Wyeth today after receiving sign-off on the deal from regulators in …
Lilly’s chief executive has unveiled a major restructuring which will see it shed 5,500 jobs, helping to cut costs and …
In retrospect, Pfizer's move to buy another major pharmaceutical company was inevitable. Like its peers, Pfizer has been energetically restructuring …
GlaxoSmithKline has expanded its restructuring plans and will make widespread job cuts in a bid to cut costs throughout its …
Another week, and another swathe of job losses across the pharmaceutical sector, with sales and back office staff once again …